FDA Status
Not FDA-Approved
Led to development of FDA-approved Bremelanotide (Vyleesi)
Claimed Benefits
- Skin pigmentation without UV
- Erectile / libido enhancement
- Appetite suppression
Clinical Evidence
4
Human Trials
Phase II
Highest Phase
Phase I/II trials showed striking erectile dysfunction efficacy, but development halted due to unacceptable side effects.
Read Full Deep Dive
Mechanism, dosing, vendor pricing, and full research citations